CMS: CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 2nd Interim Announcement

CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 2nd Interim Announcement
In the period from April 02, 2024 until and including April 05, 2024, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 102,529 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2021.
The aggregate number of shares bought back each day during the period from April 02, 2024 until and including April 05, 2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:
 

Date	Aggregate volume (number of no-par value shares)	Volume-weighted average price (in EUR, excluding ancillary costs and charges)
April 02, 2024	26,856	28.4012
April 03, 2024	21,486	27.8074
April 04, 2024	28,987	30.0733
April 05, 2024	25,200	29.9436
Total:	102,529	29.1286

The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including April 05, 2024 amounts to 177,819 shares.
Detailed information about the transactions are published on the company‘s website under https://www.cgm.com/corp_en/company/ir-en/share.html .
The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).

Koblenz, April 08, 2024

CompuGroup Medical SE & Co. KGaA
The general partner